Tumor mutation burden signatures and relation to cancer risk in humans: A pan-cancer analysis

BioRxiv : the Preprint Server for Biology
Xin Li, D. Thirumalai


Cancers, resulting in uncontrolled cell proliferation, are driven by accumulation of so- matic mutations. Whole-genome sequencing has produced a catalogue of millions of somatic mutations, which contain the evolutionary history of the cancers. However, the connection between the extent and rate of mutation accumulation and disease development and risks are poorly understood. We analyzed data from 5,000 cancer patients with more than 1,200,000 mutations for 16 cancer types using The Cancer Genome Atlas (TCGA) database to unearth markers of tumor evolution. A strong correlation between Tumor Mutation Burden (TMB) and the Patient Age at Diagno- sis (PAD) for cancers with low TMB (mean value less than 3 mutations per million base pairs) is absent in cancers with high TMB. The finding, demarcating cancers according to the TMB, resolves controversies relating the dynamics of mutation ac- cumulation and disease risks for different cancers. We also find that the differences in cancer risk between the sexes are mainly driven by the disparity in mutation burden. A simple model, explaining these results, also show that immunotherapy could work well for elderly melanoma patients.

Related Concepts

Nicotinamide adenine dinucleotide (NAD)
NADPH Dehydrogenase
Nitric Oxide
Repressor Proteins
Transcription Factor
Transcription, Genetic

Related Feeds

BioRxiv & MedRxiv Preprints

BioRxiv and MedRxiv are the preprint servers for biology and health sciences respectively, operated by Cold Spring Harbor Laboratory. Here are the latest preprint articles (which are not peer-reviewed) from BioRxiv and MedRxiv.